S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure.
TL;DR: This poster presents a probabilistic procedure to assess the importance of baseline IgE levels in the decision-making process and shows clear patterns in response to known immune-inflammatory events.
Journal ArticleDOI
Treatment of Resistant and Refractory Hypertension.
TL;DR: Refractory hypertension is defined as uncontrolled blood pressure despite use of ≥5 antihypertensive agents of different classes, including a long-acting thiazide-like diuretic and an MR (mineralocorticoid receptor) antagonist, at maximal or maximally tolerated doses.
Journal ArticleDOI
Garlic prevents hypoxic pulmonary hypertension in rats
Michael B. Fallon,Gary A. Abrams,Tarek T. Abdel-Razek,Jun Dai,Shi Juan Chen,Yiu-Fai Chen,Bao Luo,Suzanne Oparil,David D. Ku +8 more
TL;DR: It is documented that garlic blocks hypoxic pulmonary hypertension in vivo and a combination of endothelium-dependent and -independent mechanisms for the effect in pulmonary arterial rings are demonstrated.
Journal ArticleDOI
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension
Ellen Burgess,Yves Lacourcière,Luis M. Ruilope-Urioste,Suzanne Oparil,Jay H. Kleiman,Scott Krause,Barbara Roniker,Clement J. Maurath +7 more
TL;DR: Eplerenone therapy was effective in the treatment of mild to moderate hypertension over a 14-month period, either as monotherapy or in combination with another antihypertensive agent.
Journal ArticleDOI
The renal afferent nerves in the pathogenesis of hypertension
TL;DR: Peripheral renal denervation has a peripheral sympatholytic effect and alters the level of activation of central noradrenergic pathways but does not alter sodium or water intake or excretion, plasma renin activity or creatinine clearance, suggesting that efferent renal nerve function does not play an important role in the maintenance of this form of hypertension.